Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
Screening test provides prenatal risk assessment for common genetic conditions in one blood draw without the need for paternal testing
Renalytix collaborates with NYKHM to bring kidneyintelX.dkd testing to underserved communities in the Greater New York area, enabling access for over 2,000 patients.
Dr. George Katibah and Dr. Adam Grant describe the features and progress of the Company’s revolutionary technology
Two Molecular Residual Disease (MRD) studies highlighting clinical data among seven new studies to be shared by Myriad and collaborators
BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
Transforming Care for Severe AS Patients
Enhanced platform technology and the addition of a robust, high-quality CHO K-1 cell line decreases lead time to Investigational New Drug (IND)
Podium presentation showcases the clinical application of Precise™ MRD